Market revenue in 2023 | USD 901.9 million |
Market revenue in 2030 | USD 2,194.4 million |
Growth rate | 13.5% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.68% in 2024. Horizon Databook has segmented the Germany biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Robert Koch Institute, around 502,655 people were diagnosed with cancer in 2019. Thus, the high burden of cancer and the growing need for rapid diagnostics are anticipated to support the global biochip market.
An in-depth analysis of the genome of cancerous cells is important for optimal understanding of diseases to advance treatment. Hence, the German Cancer Consortium, in association with German Cancer Research, invested in the Illumina HiSeq X sequencing solution in 2015.
With the ability to sequence more than 18,000 genomes annually, it is the first and most innovative technology in the world to provide complete coverage of the entire human genome for under EUR 1,000 per genome.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany biochip market, including forecasts for subscribers. This country databook contains high-level insights into Germany biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account